| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Isosorbide mononitrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate adverse reaction |
Causative agent (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Modified release isosorbide mononitrate adverse reaction |
Causative agent (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| allergie au mononitrate d'isosorbide |
Causative agent (attribute) |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Modified release isosorbide mononitrate allergy |
Causative agent (attribute) |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate overdose |
Causative agent (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 60mg m/r capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 25mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 50mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 40mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 25mg m/r capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely isosorbide mononitrate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 60mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate+aspirin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate+aspirin 60mg/150mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate+aspirin 60mg/75mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Modified release isosorbide mononitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 30mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| allergie au mononitrate d'isosorbide |
Causative agent (attribute) |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Modified release isosorbide mononitrate allergy |
Causative agent (attribute) |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 30mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Isosorbide mononitrate 120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 25 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 25 mg prolonged-release oral capsule |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 50 mg prolonged-release oral capsule |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 50 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 50 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 50 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 40 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 40 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely isosorbide mononitrate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 20 mg oral tablet |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 40 mg oral tablet |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 30 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate 30 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only isosorbide mononitrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing isosorbide mononitrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Isosorbide mononitrate+aspirin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin and isosorbide mononitrate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]